Search Result "atypical trends"
Atypical GTPases as Drug Targets
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 1 Year: 2012 Page: 19-28
Author(s): Meera Soundararajan, Jeyanthy Eswaran
Atypical Neuroleptic Malignant Syndrome or Serotonin Toxicity Associated with Atypical Antipsychotics?
Journal: Current Drug Safety
Volume: 4 Issue: 1 Year: 2009 Page: 84-93
Author(s): Yuji Odagaki
Analytical Methods for the Determination of Atypical Antipsychotic Drugs -An Update
Journal: Current Analytical Chemistry
Volume: 19 Issue: 2 Year: 2023 Page: 147-175
Author(s):
Side Effects of Atypical Antipsychotic Drugs
Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 2219-2229
Author(s): J. Ananth, S. Parameswaran, S. Gunatilake
Role of Atypical Chemokines and Chemokine Receptors Pathways in the Pathogenesis of COPD
Journal: Current Medicinal Chemistry
Volume: 28 Issue: 13 Year: 2021 Page: 2577-2653
Author(s): Francesco Nucera,Federica Lo Bello,Sj S. Shen,Paolo Ruggeri,Irene Coppolino,Antonino Di Stefano,Cristiana Stellato,Vincenzo Casolaro,Phil M. Hansbro,Ian M. Adcock,Gaetano Caramori
Depression, Insomnia and Atypical Antidepressants
Ebook: Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Volume: 6 Year: 2018
Author(s): Laura Betti,Lionella Palego,Gino Giannaccini
Doi: 10.2174/9781681086071118060003
A Critical Review of Atypical Antipsychotic Utilization: Comparing Monotherapy with Polypharmacy and Augmentation
Journal: Current Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2004 Page: 313-327
Author(s): S. M Stahl, M. M. Grady
The Role of Atypical Antipsychotic Agents in the Treatment of Schizophrenia and Schizoaffective Disorders in the Elderly
Journal: Current Drug Safety
Volume: 1 Issue: 3 Year: 2006 Page: 227-241
Author(s): Subramoniam Madhusoodanan, Abhishek Sinha, Martha Sajatovic, Sanjay Gupta, Ronald Brenner
New Trends in the Treatment of Schizophrenia
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 8 Year: 2017 Page: 900-906
Author(s): Herbert Y. Meltzer
Partial Dopamine Receptor Agonists as Newer Atypical Antipsychotics:Intrinsic Activity Appropriate for Treatment of Schizophrenic Patients
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 7 Issue: 3 Year: 2007 Page: 156-165
Author(s): Yuji Odagaki